The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
Open accessAbstract
The bioactive lipid sphingosine-1-phosphate (S1P) is involved in multiple cellular signalling systems and has a pivotal role in the control of immune cell trafficking. As such, S1P has been implicated in disorders such as cancer and inflammatory diseases. This Review discusses the ways in which S1P might be therapeutically targeted — for example, via the development of chemical inhibitors that target the generation, transport and degradation of S1P and via the development of specific S1P receptor agonists. We also highlight recent conflicting results observed in preclinical studies targeting S1P and discuss ongoing clinical trials in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698
Haberland, M., Montgomery, R. L., & Olson, E. N. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,526
(2016) · Lung Transplantation · doi:10.3109/9781439802571-25 · Cited by 2,157
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Yu, H., Kortylewski, M., & Pardoll, D. (2007) · Nature Reviews Immunology · doi:10.1038/nri1995 · Cited by 1,804
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, J. S., & Spiegel, S. (1996) · Nature · doi:10.1038/381800a0 · Cited by 1,529
Self-citationThe Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,504
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S., & Burtin, P. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3248 · Cited by 1,273
Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C.-X., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S.-S., Lee, M.-J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10905 · Cited by 1,149
Self-citationSphingosine-1-phosphate signaling and its role in disease
Maceyka, M., Harikumar, K. B., Milstien, S., & Spiegel, S. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.003 · Cited by 1,039
Self-citationRegulation of histone acetylation in the nucleus by sphingosine-1-phosphate
Hait, N. C., Allegood, J., Maceyka, M., Strub, G. M., Harikumar, K. B., Singh, S. K., Luo, C., Marmorstein, R., Kordula, T., Milstien, S., et al. (2009) · Science · doi:10.1126/science.1176709 · Cited by 997
Self-citationWang, Z., Jiang, H., Chen, S., Du, F., & Wang, X. (2012) · Cell · doi:10.1016/j.cell.2011.11.030 · Cited by 949
Sphingosine 1-phosphate and cancer
Pyne, N. J., & Pyne, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2875 · Cited by 852
Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid Organs
Cyster, J. G., & Schwab, S. R. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075011 · Cited by 815
The outs and the ins of sphingosine-1-phosphate in immunity
Spiegel, S., & Milstien, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri2974 · Cited by 810
Self-citationLymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients
Schwab, S. R., Pereira, J. P., Matloubian, M., Xu, Y., Huang, Y., & Cyster, J. G. (2005) · Science · doi:10.1126/science.1113640 · Cited by 787
Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2
Alvarez, S. E., Harikumar, K. B., Hait, N. C., Allegood, J., Strub, G. M., Kim, E. Y., Maceyka, M., Jiang, H., Luo, C., Kordula, T., et al. (2010) · Nature · doi:10.1038/nature09128 · Cited by 752
Self-citationEssential Role for Sphingosine Kinases in Neural and Vascular Development
Mizugishi, K., Yamashita, T., Olivera, A., Miller, G. F., Spiegel, S., & Proia, R. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.11113-11121.2005 · Cited by 742
Self-citationTherapeutic application of histone deacetylase inhibitors for central nervous system disorders
Kazantsev, A. G., & Thompson, L. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2681 · Cited by 711
Teijaro, J. R., Walsh, K. B., Cahalan, S., Fremgen, D. M., Roberts, E., Scott, F., Martinborough, E., Peach, R., Oldstone, M. B. A., & Rosen, H. (2011) · Cell · doi:10.1016/j.cell.2011.08.015 · Cited by 688
Crystal Structure of a Lipid G Protein–Coupled Receptor
Hanson, M. A., Roth, C. B., Jo, E., Griffith, M. T., Scott, F. L., Reinhart, G., Desale, H., Clemons, B., Cahalan, S. M., Schuerer, S. C., et al. (2012) · Science · doi:10.1126/science.1215904 · Cited by 666
Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation.
Zhang, H., Desai, N. N., Olivera, A., Seki, T., Brooker, G., & Spiegel, S. (1991) · The Journal of cell biology · doi:10.1083/jcb.114.1.155 · Cited by 640
Self-citationChoi, J. W., Gardell, S. E., Herr, D. R., Rivera, R., Lee, C.-W., Noguchi, K., Teo, S. T., Yung, Y. C., Lu, M., Kennedy, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014154108 · Cited by 581
Liang, J., Nagahashi, M., Kim, E. Y., Harikumar, K. B., Yamada, A., Huang, W.-C., Hait, N. C., Allegood, J. C., Price, M. M., Avni, D., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.013 · Cited by 563
Self-citationThe immunosuppressant FTY720 down‐regulates sphingosine 1‐phosphate G protein‐coupled receptors
Gräler, M. H., & Goetzl, E. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-0910fje · Cited by 539
Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis
Ishii, M., Egen, J. G., Klauschen, F., Meier-Schellersheim, M., Saeki, Y., Vacher, J., Proia, R. L., & Germain, R. N. (2009) · Nature · doi:10.1038/nature07713 · Cited by 515
Visentin, B., Vekich, J. A., Sibbald, B. J., Cavalli, A. L., Moreno, K. M., Matteo, R. G., Garland, W. A., Lu, Y., Yu, S., Hall, H. S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.023 · Cited by 463
Chipuk, J. E., McStay, G. P., Bharti, A., Kuwana, T., Clarke, C. J., Siskind, L. J., Obeid, L. M., & Green, D. R. (2012) · Cell · doi:10.1016/j.cell.2012.01.038 · Cited by 436
Sanna, M. G., Wang, S.-K., Gonzalez-Cabrera, P. J., Don, A., Marsolais, D., Matheu, M. P., Wei, S. H., Parker, I., Jo, E., Cheng, W.-C., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio804 · Cited by 406
The Sphingolipid Transporter Spns2 Functions in Migration of Zebrafish Myocardial Precursors
Kawahara, A., Nishi, T., Hisano, Y., Fukui, H., Yamaguchi, A., & Mochizuki, N. (2009) · Science · doi:10.1126/science.1167449 · Cited by 405
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors
Lee, H., Deng, J., Kujawski, M., Yang, C., Liu, Y., Herrmann, A., Kortylewski, M., Horne, D., Somlo, G., Forman, S., et al. (2010) · Nature Medicine · doi:10.1038/nm.2250 · Cited by 395
Strub, G. M., Paillard, M., Liang, J., Gomez, L., Allegood, J. C., Hait, N. C., Maceyka, M., Price, M. M., Chen, Q., Simpson, D. C., et al. (2011) · The FASEB Journal · doi:10.1096/fj.10-167502 · Cited by 379
Self-citationTargeting the correct HDAC(s) to treat cognitive disorders
Fischer, A., Sananbenesi, F., Mungenast, A., & Tsai, L.-H. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.09.003 · Cited by 354
An update on sphingosine-1-phosphate and other sphingolipid mediators
Fyrst, H., & Saba, J. D. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.392 · Cited by 344
Neviani, P., Santhanam, R., Oaks, J. J., Eiring, A. M., Notari, M., Blaser, B. W., Liu, S., Trotta, R., Muthusamy, N., Gambacorti-Passerini, C., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31095 · Cited by 335
T-bet–dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow
Jenne, C. N., Enders, A., Rivera, R., Watson, S. R., Bankovich, A. J., Pereira, J. P., Xu, Y., Roots, C. M., Beilke, J. N., Banerjee, A., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090525 · Cited by 334
Fukuhara, S., Simmons, S., Kawamura, S., Inoue, A., Orba, Y., Tokudome, T., Sunden, Y., Arai, Y., Moriwaki, K., Ishida, J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60746 · Cited by 324
Flow-Regulated Endothelial S1P Receptor-1 Signaling Sustains Vascular Development
Jung, B., Obinata, H., Galvani, S., Mendelson, K., Ding, B.-S., Skoura, A., Kinzel, B., Brinkmann, V., Rafii, S., Evans, T., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.07.015 · Cited by 317
Gaengel, K., Niaudet, C., Hagikura, K., Laviña, B., Muhl, L., Hofmann, J. J., Ebarasi, L., Nyström, S., Rymo, S., Chen, L. L., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.08.005 · Cited by 317
Pharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2
French, K. J., Zhuang, Y., Maines, L. W., Gao, P., Wang, W., Beljanski, V., Upson, J. J., Green, C. L., Keller, S. N., & Smith, C. D. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163444 · Cited by 317
Nagahashi, M., Ramachandran, S., Kim, E. Y., Allegood, J. C., Rashid, O. M., Yamada, A., Zhao, R., Milstien, S., Zhou, H., Spiegel, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2167 · Cited by 315
Self-citationGergely, P., Nuesslein‐Hildesheim, B., Guerini, D., Brinkmann, V, Traebert, M., Bruns, C., Pan, S., Gray, N., Hinterding, K., Cooke, N., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02061.x · Cited by 305
Ruckhäberle, E., Rody, A., Engels, K., Gaetje, R., von Minckwitz, G., Schiffmann, S., Grösch, S., Geisslinger, G., Holtrich, U., Karn, T., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9836-9 · Cited by 302
Ding, B. B., Yu, J. J., Yu, R. Y.-L., Mendez, L. M., Shaknovich, R., Zhang, Y., Cattoretti, G., & Ye, B. H. (2008) · Blood · doi:10.1182/blood-2007-04-087734 · Cited by 298
Role for sphingosine kinase 1 in colon carcinogenesis
Kawamori, T., Kaneshiro, T., Okumura, M., Maalouf, S., Uflacker, A., Bielawski, J., Hannun, Y. A., & Obeid, L. M. (2009) · The FASEB Journal · doi:10.1096/fj.08-117572 · Cited by 280
Dendritic cell PAR1–S1P3 signalling couples coagulation and inflammation
Niessen, F., Schaffner, F., Furlan-Freguia, C., Pawlinski, R., Bhattacharjee, G., Chun, J., Derian, C. K., Andrade-Gordon, P., Rosen, H., & Ruf, W. (2008) · Nature · doi:10.1038/nature06663 · Cited by 280
Schnute, M. E., McReynolds, M. D., Kasten, T., Yates, M., Jerome, G., Rains, J. W., Hall, T., Chrencik, J., Kraus, M., Cronin, C. N., et al. (2012) · Biochemical Journal · doi:10.1042/bj20111929 · Cited by 280
Sphingosine 1-Phosphate Analogs as Receptor Antagonists
Davis, M. D., Clemens, J. J., Macdonald, T. L., & Lynch, K. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412356200 · Cited by 269
Saddoughi, S. A., Gencer, S., Peterson, Y. K., Ward, K. E., Mukhopadhyay, A., Oaks, J., Bielawski, J., Szulc, Z. M., Thomas, R. J., Selvam, S. P., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201283 · Cited by 264
Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo
Ishii, M., Kikuta, J., Shimazu, Y., Meier-Schellersheim, M., & Germain, R. N. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101474 · Cited by 253
S1PR1-STAT3 Signaling Is Crucial for Myeloid Cell Colonization at Future Metastatic Sites
Deng, J., Liu, Y., Lee, H., Herrmann, A., Zhang, W., Zhang, C., Shen, S., Priceman, S. J., Kujawski, M., Pal, S. K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.039 · Cited by 252
Paugh, S. W., Paugh, B. S., Rahmani, M., Kapitonov, D., Almenara, J. A., Kordula, T., Milstien, S., Adams, J. K., Zipkin, R. E., Grant, S., et al. (2008) · Blood · doi:10.1182/blood-2008-02-138958 · Cited by 244
Self-citationJo, E., Sanna, M. G., Gonzalez-Cabrera, P. J., Thangada, S., Tigyi, G., Osborne, D. A., Hla, T., Parrill, A. L., & Rosen, H. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.04.019 · Cited by 240
Sukocheva, O., Wadham, C., Holmes, A., Albanese, N., Verrier, E., Feng, F., Bernal, A., Derian, C. K., Ullrich, A., Vadas, M. A., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200506033 · Cited by 228
Sphingosine-1-Phosphate and Its Receptors: Structure, Signaling, and Influence
Rosen, H., Stevens, R. C., Hanson, M., Roberts, E., & Oldstone, M. B. A. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062411-130916 · Cited by 221
Mouse SPNS2 Functions as a Sphingosine-1-Phosphate Transporter in Vascular Endothelial Cells
Hisano, Y., Kobayashi, N., Yamaguchi, A., & Nishi, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038941 · Cited by 209
Molecular Basis of Sphingosine Kinase 1 Substrate Recognition and Catalysis
Wang, Z., Min, X., Xiao, S.-H., Johnstone, S., Romanow, W., Meininger, D., Xu, H., Liu, J., Dai, J., An, S., et al. (2013) · Structure · doi:10.1016/j.str.2013.02.025 · Cited by 187
Kapitonov, D., Allegood, J. C., Mitchell, C., Hait, N. C., Almenara, J. A., Adams, J. K., Zipkin, R. E., Dent, P., Kordula, T., Milstien, S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0664 · Cited by 182
Self-citationBACE1 activity is modulated by cell-associated sphingosine-1-phosphate
Takasugi, N., Sasaki, T., Suzuki, K., Osawa, S., Isshiki, H., Hori, Y., Shimada, N., Higo, T., Yokoshima, S., Fukuyama, T., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6467-10.2011 · Cited by 181
2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1Receptor Agonists
Bolli, M. H., Abele, S., Binkert, C., Bravo, R., Buchmann, S., Bur, D., Gatfield, J., Hess, P., Kohl, C., Mangold, C., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100181s · Cited by 179
Allende, M. L., Bektas, M., Lee, B. G., Bonifacino, E., Kang, J., Tuymetova, G., Chen, W., Saba, J. D., & Proia, R. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.171819 · Cited by 177
Nakahara, K., Ohkuni, A., Kitamura, T., Abe, K., Naganuma, T., Ohno, Y., Zoeller, R. A., & Kihara, A. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.033 · Cited by 174
Export and functions of sphingosine-1-phosphate
Kim, R. H., Takabe, K., Milstien, S., & Spiegel, S. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.02.011 · Cited by 172
Self-citationWatson, C., Long, J. S., Orange, C., Tannahill, C. L., Mallon, E., McGlynn, L. M., Pyne, S., Pyne, N. J., & Edwards, J. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100220 · Cited by 172
Skoura, A., Michaud, J., Im, D.-S., Thangada, S., Xiong, Y., Smith, J. D., & Hla, T. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.213496 · Cited by 170
Sammani, S., Moreno-Vinasco, L., Mirzapoiazova, T., Singleton, P. A., Chiang, E. T., Evenoski, C. L., Wang, T., Mathew, B., Husain, A., Moitra, J., et al. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0223oc · Cited by 168
The Transporter Spns2 Is Required for Secretion of Lymph but Not Plasma Sphingosine-1-Phosphate
Mendoza, A., Bréart, B., Ramos-Perez, W. D., Pitt, L. A., Gobert, M., Sunkara, M., Lafaille, J. J., Morris, A. J., & Schwab, S. R. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.021 · Cited by 167
A Phase I Clinical Trial of Safingol in Combination with Cisplatin in Advanced Solid Tumors
Dickson, M. A., Carvajal, R. D., Merrill, A. H., Gönen, M., Cane, L. M., & Schwartz, G. K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2323 · Cited by 164
Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling
Nagata, Y., Partridge, T. A., Matsuda, R., & Zammit, P. S. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200605028 · Cited by 160
Nagahashi, M., Kim, E. Y., Yamada, A., Ramachandran, S., Allegood, J. C., Hait, N. C., Maceyka, M., Milstien, S., Takabe, K., & Spiegel, S. (2013) · The FASEB Journal · doi:10.1096/fj.12-219618 · Cited by 160
Self-citationFoss, F. W., Snyder, A. H., Davis, M. D., Rouse, M., Okusa, M. D., Lynch, K. R., & Macdonald, T. L. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.10.060 · Cited by 158
A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells
Matsuoka, Y., Nagahara, Y., Ikekita, M., & Shinomiya, T. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705182 · Cited by 152
Ponnusamy, S., Selvam, S. P., Mehrotra, S., Kawamori, T., Snider, A. J., Obeid, L. M., Shao, Y., Sabbadini, R. A., & Öğretmen, B. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200244 · Cited by 147
Liu, Q., Zhao, X. B., Frissora, F. W., Ma, Y., Santhanam, R., Jarjoura, D. G., Lehman, A., Perrotti, D., Chen, C., Dalton, J. T., et al. (2007) · Blood · doi:10.1182/blood-2006-10-053884 · Cited by 146
Price, M. M., Oskeritzian, C. A., Falanga, Y. T., Harikumar, K. B., Allegood, J. C., Alvarez, S. E., Conrad, D. H., Ryan, J. J., Milstien, S., & Spiegel, S. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.014 · Cited by 144
Self-citationKikuta, J., Kawamura, S., Okiji, F., Shirazaki, M., Sakai, S., Saitô, H., & Ishii, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218799110 · Cited by 140
Roberts, K. G., Smith, A. M., McDougall, F. K., Carpenter, H., Horan, M. P., Neviani, P., Powell, J. A., Thomas, D., Guthridge, M. A., Perrotti, D., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2544 · Cited by 133
S1P1-selective agonist, SEW2871, ameliorates ischemic acute renal failure
Lien, Y.-H. H., Yong, K.-C., Cho, C., Igarashi, S., & Lai, L. (2006) · Kidney International · doi:10.1038/sj.ki.5000360 · Cited by 132
Gonzalez‐Cabrera, P. J., Jo, E., Sanna, M., Brown, S. J., Leaf, N. B., Marsolais, D., Schaeffer, M., Chapman, J. V., Cameron, M. D., Guerrero, M., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.049783 · Cited by 129
A Potent and Selective S1P1 Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis
Quancard, J., Bollbuck, B., Janser, P., Angst, D., Berst, F., Buehlmayer, P., Streiff, M. B., Beerli, C., Brinkmann, V., Guerini, D., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.07.016 · Cited by 128
Shimizu, H., Takahashi, M., Kaneko, T., Murakami, T., Hakamata, Y., Kudou, S., Kishi, T., Fukuchi, K., Iwanami, S., Kuriyama, K., et al. (2005) · Circulation · doi:10.1161/01.cir.0000152101.41037.ab · Cited by 127
Gandy, K. A. O., & Obeid, L. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.002 · Cited by 125
Yang, L., Yue, S., Yang, L., Liu, X., Han, Z., Zhang, Y., & Li, L. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.021 · Cited by 125
Marsolais, D., Hahm, B., Walsh, K. B., Edelmann, K. H., McGavern, D., Hatta, Y., Kawaoka, Y., Rosen, H., & Oldstone, M. B. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812689106 · Cited by 122
Schulze, T., Golfier, S., Tabeling, C., Räbel, K., Gräler, M. H., Witzenrath, M., & Lipp, M. (2011) · The FASEB Journal · doi:10.1096/fj.10-179028 · Cited by 118
Bagdanoff, J. T., Donoviel, M. S., Nouraldeen, A. M., Carlsen, M., Jessop, T. C., Tarver, J., Aleem, S., Dong, L., Zhang, H., Boteju, L. W., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101183p · Cited by 117
Antiestrogenic Effects of the Novel Sphingosine Kinase-2 Inhibitor ABC294640
Antoon, J. W., White, M. D., Meacham, W. D., Slaughter, E. M., Muir, S. E., Elliott, S. G., Rhodes, L. V., Ashe, H., Wiese, T. E., Smith, C. D., et al. (2010) · Endocrinology · doi:10.1210/en.2010-0420 · Cited by 117
STAT3 Inhibition Is a Therapeutic Strategy for ABC-like Diffuse Large B-Cell Lymphoma
Scuto, A., Kujawski, M., Kowolik, C. M., Krymskaya, L., Wang, L., Weiss, L. M., DiGiusto, D. L., Yu, H., Forman, S. J., & Jove, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2380 · Cited by 116
S1P1 inhibits sprouting angiogenesis during vascular development
Shoham, A. B., Malkinson, G., Krief, S., Shwartz, Y., Ely, Y., Ferrara, N., Yaniv, K., & Zelzer, E. (2012) · Development · doi:10.1242/dev.078550 · Cited by 116
Characterization of Isoenzyme-Selective Inhibitors of Human Sphingosine Kinases
Gao, P., Peterson, Y. K., Smith, R. A., & Smith, C. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044543 · Cited by 110
Piali, L., Froidevaux, S., Hess, P., Nayler, O., Bolli, M. H., Schlosser, E., Kohl, C., Steiner, B., & Clozel, M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.176487 · Cited by 110
Lipid phosphate phosphatase 3 enables efficient thymic egress
Bréart, B., Ramos-Pérez, W. D., Mendoza, A., Salous, A. K., Gobert, M., Huang, Y., Adams, R. H., Lafaille, J. J., Escalante‐Alcalde, D., Morris, A. J., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20102551 · Cited by 109
Liu, Y., Deng, J., Wang, L., Lee, H., Armstrong, B., Scuto, A., Kowolik, C. M., Weiss, L. M., Forman, S. J., & Yu, H. (2012) · Blood · doi:10.1182/blood-2011-12-399030 · Cited by 104
Chumanevich, A. A., Poudyal, D., Cui, X., Davis, T., Wood, P. A., Smith, C. D., & Hofseth, L. J. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq158 · Cited by 102
Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate
Kharel, Y., Raje, M. R., Gao, M. Z., Gellett, A. M., Tomsig, J. L., Lynch, K. R., & Santos, W. L. (2012) · Biochemical Journal · doi:10.1042/bj20120609 · Cited by 100
Song, J., Matsuda, C., Kai, Y., Nishida, T., Nakajima, K., Mizushima, T., Kinoshita, M., Yasue, T., Sawa, Y., & Ito, T. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.119172 · Cited by 98
Frost, D. B., Barth, J. L., Chang, R. C., Obeid, L. M., & Gilkeson, G. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000644 · Cited by 95
Awad, A. S., Rouse, M. D., Khutsishvili, K., Huang, L., Bolton, W. K., Lynch, K. R., & Okusa, M. D. (2011) · Kidney International · doi:10.1038/ki.2010.544 · Cited by 93
Ikeda, H. (2003) · Gastroenterology · doi:10.1053/gast.2003.50049 · Cited by 91
Caballero, S., Swaney, J. S., Moreno, K. M., Afzal, A., Kielczewski, J. L., STOLLER, G. L., Cavalli, A. L., Garland, W., Hansen, G., Sabbadini, R. A., et al. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.07.012 · Cited by 90
Sphingosine Kinase Inhibitors and Cancer: Seeking the Golden Sword of Hercules
Pyne, S., Bittman, R., & Pyne, N. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2364 · Cited by 89
Loh, K. C., Leong, W.-I., Carlson, M. E., Oskouian, B., Kumar, A., Fyrst, H., Zhang, M., Proia, R. L., Hoffman, E. P., & Saba, J. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037218 · Cited by 87
Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn’s disease
Maines, L. W., Fitzpatrick, L. R., Green, C. L., Zhuang, Y., & Smith, C. D. (2010) · Inflammopharmacology · doi:10.1007/s10787-010-0032-x · Cited by 86
Long, J. S., Fujiwara, Y., Edwards, J., Tannahill, C. L., Tigyi, G., Pyne, S., & Pyne, N. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.117945 · Cited by 86
Gomez, L., Paillard, M., Price, M. M., Chen, Q., Teixeira, G., Spiegel, S., & Lesnefsky, E. J. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0223-7 · Cited by 83
Self-citationTruth and consequences of sphingosine-1-phosphate lyase
Aguilar, A. G., & Saba, J. D. (2011) · Advances in Biological Regulation · doi:10.1016/j.advenzreg.2011.09.015 · Cited by 81
Translational aspects of sphingosine 1-phosphate biology
Pyne, S., & Pyne, N. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.03.002 · Cited by 80
Salomone, S., & Waeber, C. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00009 · Cited by 79
Structure and Function of Sphingosine-1-Phosphate Lyase, a Key Enzyme of Sphingolipid Metabolism
Bourquin, F., Riezman, H., Capitani, G., & Grütter, M. G. (2010) · Structure · doi:10.1016/j.str.2010.05.011 · Cited by 76
Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate
Kharel, Y., Mathews, T. P., Gellett, A. M., Tomsig, J. L., Kennedy, P., Moyer, M. L., Macdonald, T. L., & Lynch, K. R. (2011) · Biochemical Journal · doi:10.1042/bj20110817 · Cited by 74
S1P Is Associated with Protection in Human and Experimental Cerebral Malaria
Finney, C. A. M., Hawkes, C. A., Kain, D. C., Dhabangi, A., Musoke, C., Cserti-Gazdewich, C. M., Oravecz, T., Liles, W. C., & Kain, K. C. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00214 · Cited by 69
Tarrasón, G., Aulí, M., Mustafa, S., Dolgachev, V. A., Domènech, T., Prats, N., Domínguez, M., López, R., Aguilar, N., Calbet, M., et al. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.07.004 · Cited by 66
Fingolimod treatment in multiple sclerosis leads to increased macular volume
Nolan, R. C., Gelfand, J. M., & Green, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31827b9132 · Cited by 62
Sphingosine 1-Phosphate Mediates Hyperalgesia via a Neutrophil-Dependent Mechanism
Finley, A., Chen, Z., Esposito, E., Cuzzocrea, S., Sabbadini, R. A., & Salvemini, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055255 · Cited by 61
Fujii, Y., Hirayama, T., Ohtake, H., Ono, N., Inoue, T., Sakurai, T., Takayama, T., Matsumoto, K., Tsukahara, N., Hidano, S., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101537 · Cited by 61
Wenderfer, S. E., Stepkowski, S. M., & Braun, M. (2008) · Kidney International · doi:10.1038/ki.2008.396 · Cited by 59
Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase
Fitzpatrick, L. R., Green, C., Frauenhoffer, E. E., French, K. J., Zhuang, Y., Maines, L. W., Upson, J. J., Paul, E. M., Donahue, H. J., Mosher, T. J., et al. (2010) · Inflammopharmacology · doi:10.1007/s10787-010-0060-6 · Cited by 57
Therapeutic Effects of Novel Sphingosine-1-Phosphate Receptor Agonist W-061 in Murine DSS Colitis
Sanada, Y., Mizushima, T., Kai, Y., Nishimura, J., Hagiya, H., Kurata, H., Mizuno, H., Uejima, E., & Ito, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023933 · Cited by 56
Discovery of CS-0777: A Potent, Selective, and Orally Active S1P1 Agonist
Nishi, T., Miyazaki, S., Takemoto, T., Suzuki, K., Iio, Y., Nakajima, K., Ohnuki, T., Kawase, Y., Nara, F., Inaba, S., et al. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100301k · Cited by 51
Komiya, T., Sato, K., Shioya, H., Inagaki, Y., Hagiya, H., Kozaki, R., Meroni, I. M. A. I., Takada, Y., Maeda, T., Kurata, H., et al. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04669.x · Cited by 49
Antoon, J. W., Meacham, W. D., Bratton, M. R., Slaughter, E. M., Rhodes, L. V., Ashe, H., Wiese, T. E., Burow, M. E., & Beckman, B. S. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-10-0116 · Cited by 49
Kluk, M., Ryan, K. P., Wang, B., Zhang, G., Rodig, S. J., & Sánchez, T. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.7 · Cited by 48
Fingolimod Therapy for Multiple Sclerosis
Willis, M. A., & Cohen, J. A. (2013) · Seminars in Neurology · doi:10.1055/s-0033-1343794 · Cited by 48
Samy, E. T., Meyer, C. A., Caplazi, P., Langrish, C. L., Lora, J. M., Bluethmann, H., & Peng, S. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.5644 · Cited by 47
AUY954, a selective S1P1 modulator, prevents experimental autoimmune neuritis
Zhang, Z., Zhang, Z., Zug, C., Nuesslein‐Hildesheim, B., Leppert, D., & Schluesener, H. J. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.09.010 · Cited by 46
Vessey, D. A., Li, L., Jin, Z.-Q., Kelley, M., Honbo, N. Y., Zhang, J., & Karliner, J. S. (2011) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2011/961059 · Cited by 46
Clemens, J. J., Davis, M. D., Lynch, K. R., & Macdonald, T. L. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.07.030 · Cited by 44
Ihlefeld, K., Claas, R. F., Koch, A. H., Pfeilschifter, J. M., & zu Heringdorf, D. M. (2012) · Biochemical Journal · doi:10.1042/bj20120811 · Cited by 41
Pyne, S., Edwards, J., Ohotski, J., & Pyne, N. J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00168 · Cited by 41
Galicia, G., Pikor, N. B., Schwartz, J. A., Rojas, O. L., Jian, A., deLuca, L. S., Ostrowski, M., Nuesslein‐Hildesheim, B., & Gommerman, J. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102261 · Cited by 38
Liu, Q., Rehman, H., Shi, Y., Krishnasamy, Y., Lemasters, J. J., Smith, C. D., & Zhong, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041834 · Cited by 38
Potì, F., Costa, S., Bergonzini, V., Galletti, M., Pignatti, E., Weber, C., Simoni, M., & Nofer, J. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.03.003 · Cited by 38
Genetic elevation of Sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila
Pantoja, M., Fischer, K. A., Ieronimakis, N. M., Reyes, M., & Ruohola‐Baker, H. (2012) · Development · doi:10.1242/dev.087791 · Cited by 36
Cited by
Lipid metabolic reprogramming in cancer cells
Beloribi-Djefaflia, S., Vasseur, S., & Guillaumond, F. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.49 · Cited by 1,398
Natural product and natural product derived drugs in clinical trials
Butler, M. S., Robertson, A. A. B., & Cooper, M. A. (2014) · Nat. Prod. Rep. · doi:10.1039/c4np00064a · Cited by 602
Kuswanto, W., Burzyn, D., Panduro, M., Wang, K. K., Jang, Y. C., Wagers, A. J., Benoist, C., & Mathis, D. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.009 · Cited by 517
An update on the biology of sphingosine 1-phosphate receptors
Blaho, V. A., & Hla, T. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046300 · Cited by 516
STAT3 Target Genes Relevant to Human Cancers
Carpenter, R., & Lo, H.-W. (2014) · Cancers · doi:10.3390/cancers6020897 · Cited by 511
Metadata
- Authors
- Kunkel, G. T., Maceyka, M., Milstien, S., & Spiegel, S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2013-08-19
- Volume
- 12
- Issue
- 9
- Pages
- 688-702
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2070261634
- Cited by
- 434
- References
- 135
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.